Christian Ewald, Nov 01, 2008
It seems fairly unlikely that the seminal papers of Professor Joseph A. Schumpeter would today have a good chance to be published in one of the leading journals specialized in industrial organization. This judgment, however, is a remarkable contrast with his still profound relevance in the world of antitrust. His warning that putting too much emphasis on static efficiency may risk killing endogenous technological change and growth has already inspired numerous policy debates in the past. A new paper by David S. Evans and Keith N. Hylton provides telling evidence that this is still true exactly 100 years after Schumpeter, for the first time, outlined the basis of what is known today as Schumpeterian tradeoff…. My comments on Evans & Hylton´s arguments are twofold: First, I consider it necessary to put at least two question marks behind their diagnosis that there is a severe risk of a myopic application of state-of-play antitrust economics. Second, in my view at least two further qualifications have to be made regarding Evans & Hylton´s perception of the scope and limitations of antitrust enforcement which explicitly or implicitly drives their argument. Both pillars together carry my view that to stay within the picture prescribing antitrust enforcers strong glasses which are in the risk of leading to a severe hyperopia or even blindness seems not to be a suitable therapy for an alleged myopia in antitrust; the Schumpeterian tradeoff should not provide the justification for an overly cautious hands-off approach.
Links to Full Content
Featured News
Congress Pushes to Combat AI Deepfakes in Year-End Funding Deal
Dec 18, 2024 by
CPI
Epic Games Board Resignations Linked to DOJ Antitrust Investigation
Dec 18, 2024 by
CPI
Renault Supports Potential Honda-Nissan Merger Talks
Dec 18, 2024 by
CPI
South Korea’s Antitrust Body Raises Concerns Over AI Market Competition
Dec 18, 2024 by
CPI
Perplexity Caught in Crossfire as DOJ and Google Battle Over Search Dominance
Dec 18, 2024 by
CPI
Antitrust Mix by CPI
Remedies After Illumina/GRAIL– The Thorny Question of Proportionality
Dec 17, 2024 by
Aleksander Tombinski & Ciara Denihan
Why Was Illumina/GRAIL Blocked in the EU? Reviewing The European Commission’s Assessment of Vertical Mergers in Light of the 2022 Prohibition Decision
Dec 17, 2024 by
Will Sparks
The Role of Uncertainty in the Future European Horizontal Merger Guidelines: Lessons Learned From Illumina/GRAIL
Dec 17, 2024 by
Svend Albaek & Daniel Donath
Illumina’s Light on Article 22 EUMR: The Suspended Step and Uncertain Future of EU Merger Control Over Below-Threshold “Killer” Mergers
Dec 17, 2024 by
Anna Tzanaki
EU-Level Jurisdiction Over “Killer Acquisitions” in the Aftermath of Illumina/GRAIL
Dec 17, 2024 by
Peter Whelan